Efficacy of convalescent plasma therapy in the patient with COVID-19: a randomised control trial (COPLA-II trial) | BMJ Open

Log In More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Archive

For authors

About

Browse by collection
Log in More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals

Article metrics

PDF +
Supplementary
Material

Haematology (incl blood transfusion)

Original research

Efficacy of convalescent plasma therapy in the patient with COVID-19: a randomised control trial (COPLA-II trial)

Online download statistics by month:

Online download statistics by month: April 2022 to April 2024

	Abstract	Full	Pdf
Apr 2022	917	903	115
May 2022	230	237	83
Jun 2022	140	138	54
Jul 2022	150	154	25
Aug 2022	177	178	30
Sep 2022	66	59	21
Oct 2022	70	62	46
Nov 2022	75	71	30
Dec 2022	66	64	31
Jan 2023	78	73	20
Feb 2023	67	71	26
Mar 2023	63	68	28
Apr 2023	43	40	17
May 2023	44	44	15
Jun 2023	37	36	12
Jul 2023	41	40	16
Aug 2023	55	56	22
Sep 2023	49	51	18
Oct 2023	109	110	9
Nov 2023	264	268	16
Dec 2023	68	64	15
Jan 2024	23	20	12
Feb 2024	39	39	10
Mar 2024	73	71	69
Apr 2024	20	19	8
Total	2964	2936	748